In Reply Our Viewpoint discussing the adoption of robotic surgery in the United States was intended to facilitate important conversations.1 We agree with Dr Curet that a combination of regulators (FDA), innovators (Intuitive), and clinical leaders are all necessary to ensure that existing safeguards are effective. The FDA’s medical device approval process will rely on the early experience of Intuitive as new companies enter the robotic surgical market in years to come.
Sheetz KH, Dimick JB. Issues in the Adoption of Robotic Surgery—Reply. JAMA. 2019;322(14):1414–1415. doi:10.1001/jama.2019.12188
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: